Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report.

Mrinal GuptaPaul S YamauchiMartine BagotJacek SzepietowskiShibani BhatiaTorello LottiMohammad Goldust

Published in: Clinical case reports (2020)

Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.

Keyphrases

multiple sclerosis
dendritic cells
white matter
case report
mass spectrometry
ms ms
soft tissue
combination therapy